Global Organoid Technology Market: Market Research by Knowledge Sourcing Intelligence

The global organoid technology market is expected to grow at a CAGR of XX.XX% to reach a total market size of US$XX.XX million by 2023, increasing from US$XX.XX million in 2017. The organoid technology has gained a significant focus of both government and private players owing to its ability to provide more physiologically relevant and accurate data for the various in-vivo test. They are widely being used in various application such as disease pathology, tissue morphogenesis, and engineering, gene and protein expression, regenerative medicine, and others. This has led to increased investment in healthcare research and development in the field of Organoid technology which is expected to be the major driving force for this market. The extensive benefits of this technology in cancer research has resulted in various international collaborations to create new cancer models which are further expected to accelerate research activities.